LJHT
ECYT

Laurie J. Hall Trustee’s Endocyte, Inc. Common Stock ECYT Stock Holding History

Laurie J. Hall Trustee’s Portfolio ECYT Stock Details ECYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-270
Closed -$405 – 304
2017
Q2 		$405 Hold
270
– – ﹤0.01% 302
2017
Q1 		$651 Hold
270
– – ﹤0.01% 304
2016
Q4 		$1K Buy
+270
New +$775 ﹤0.01% 298
2016
Q2 		$1K Buy
270
+140
+108% +$513 ﹤0.01% 299
2016
Q1 		$1K Buy
+130
New +$424 ﹤0.01% 297

Other funds holding ECYT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
CRC
Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Laurie J. Hall Trustee's ECYT Position: Q3 2017 in Review

Laurie J. Hall Trustee sold out of Endocyte, Inc. Common Stock (ECYT) in Q3 2017, closing a stake of 270 shares — an estimated $405 sold.

Laurie J. Hall Trustee first reported a position in ECYT in Q1 2016 and held it in 5 quarters. The position peaked at $1K in Q4 2016. 63 funds tracked by Wall St. Rank hold ECYT as of Q3 2017.

  • Laurie J. Hall Trustee reported no remaining Endocyte, Inc. Common Stock position as of Q3 2017 after selling out during the quarter.
  • Laurie J. Hall Trustee sold 270 Endocyte, Inc. Common Stock shares in Q3 2017, an estimated $405.
  • Laurie J. Hall Trustee first reported a position in Endocyte, Inc. Common Stock in Q1 2016 and held it in 5 quarters.
  • Laurie J. Hall Trustee's Endocyte, Inc. Common Stock position peaked at $1K in Q4 2016.
  • 63 funds tracked by Wall St. Rank held Endocyte, Inc. Common Stock as of Q3 2017.

Based on Laurie J. Hall Trustee's 13F filing for Q3 2017, filed 2 Oct 2017.